assessment
Search documents
QHSLab (OTCQB:USAQ) Initiates Board Expansion Process to Strengthen Governance and Support Next Phase of Growth
Globenewswire· 2026-01-16 13:00
Governance evolution follows elimination of major convertible debt, recent funding, and improved capital structure Company advances governance framework aligned with shareholder interests and future listing requirements West Palm Beach, FL, Jan. 16, 2026 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health infrastructure company supporting primary care practices, today announced that it has initiated a formal process to expand its board of directors by adding independent members. ...
QHSLab (OTCQB:USAQ) Issues Unaudited Financial and Operational Update Ahead of January 2026 Investor Session
Globenewswire· 2026-01-06 14:44
Unaudited update reflects revenue growth, positive operating income, removal of convertible debt, and improved cash flow profile entering 2026. Company reports $1.99 million in revenue for the nine months ended September 30, 2025, up 32% YoY, eliminates convertible debt, and ends the year with approximately $630,000 in cash. West Palm Beach, FL, Jan. 06, 2026 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health infrastructure company focused on supporting primary care practices, t ...
QHSLab, Inc. (OTCQB:USAQ) Completes $500K Private Placement, Enters 2026 With Clean Capital Structure
Globenewswire· 2025-12-29 13:30
With legacy overhang removed and new capital secured, management shifts focus from balance-sheet repair to disciplined growth execution. West Palm Beach, FL, Dec. 29, 2025 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a healthcare technology company focused on digital medicine and population health innovation, today announced the completion of a $500,000 private placement with accredited investors, providing fresh growth capital and further strengthening the Company’s balance sheet followin ...
QHSLab, Inc. (OTCQB:USAQ) Completes $500K Private Placement, Enters 2026 With Clean Capital Structure
Globenewswire· 2025-12-29 13:30
Core Viewpoint - QHSLab Inc. has successfully completed a $500,000 private placement, enhancing its balance sheet and shifting focus from debt management to disciplined growth execution [1][4]. Financial Restructuring - The company retired over $1.4 million of legacy convertible notes, which had an 18% default interest rate and conversion rights at $0.20 per share, eliminating potential dilution and over $200,000 in annual interest expenses [2][3]. - The combination of eliminating high-cost convertible debt and securing new equity capital has improved the company's liquidity and financial flexibility [3]. Growth Strategy - QHSLab plans to utilize the new capital for targeted sales and marketing efforts, expanding its medical practice client base, onboarding capacity, and customer support activities [3]. - The company aims to increase its physician client base, recurring assessment volume, revenues, and operational efficiencies [3]. Investor Confidence - The recent capital raise was entirely in common stock and long-term warrants, aligning investors with management's long-term growth strategy [4]. - An investor expressed confidence in QHSLab's trajectory, indicating a positive outlook on the company's future [4]. Management Commentary - The President and CEO emphasized that the financing, while modest, marks a significant turning point for the company, allowing it to focus on scaling its digital medicine programs and driving recurring revenue growth [5]. - The company enters 2026 with a cleaner capital structure, positioning it to prioritize disciplined growth and shareholder value [5]. Recent Financial Highlights - For the first nine months of 2025, QHSLab reported revenues of $1.99 million, a 32% increase year-over-year, and a gross profit of $1.32 million, reflecting a 66% gross margin [6].
Derivita and Texas Instruments Partner to Advance High-Quality Math in the Thinking Classroom Through Seamless Integration
Prnewswire· 2025-06-04 14:30
Core Insights - Derivita has announced a partnership with Texas Instruments (TI) to enhance math education through the integration of Derivita's platform with TI's TI-Nspire™ CX II graphing calculator, aiming to create dynamic and engaging classroom environments [2][4][9] - The collaboration focuses on real-time student engagement and formative assessment, allowing teachers to facilitate anonymous participation and peer collaboration, thus improving the learning experience [3][6][8] Company Overview - Derivita is positioned as an all-in-one math platform catering to grades 6 through Calculus III, emphasizing equitable access to high-quality math education through technology [2][11] - Texas Instruments has a long-standing reputation in math education, providing tools that minimize distractions and enhance student focus, which aligns with Derivita's mission [5][12] Product Features - The integration of Derivita's SpotCheck feature with TI's graphing calculator allows for real-time problem-solving and class discussions, transforming individual work into collaborative learning experiences [3][6][7] - Teachers can project problems on smartboards while students solve them on their calculators, enabling instant feedback and fostering a culture of active participation [6][8] Market Position - Derivita is backed by prominent investors in K–12 education technology, indicating strong confidence in its innovative approach to math instruction and its potential to impact learning outcomes at scale [9][10] - The partnership with TI reflects a shared commitment to improving math proficiency as a foundation for college and career readiness, leveraging technology to provide equitable access to education [9][10]